Table 2

Clinical and molecular parameters of breast cancers. Clinical and molecular parameters are given for each breast cancer used in this study. Module scores for each tumor were calculated from the results based on intact RNA (FF material) and based on RNA isolated from FFPE material according to our own method. N.A., data not available.

Clinical classification
 Immunohistochemistry
 Module Score (FF/FFPE)


Tu#
 T
 N
 Grade
 ER
 PR
 ErbB2
 ER
 HER2
 Prolif.
 Histological type
2
 2
 0
 3
 70% pos.
 neg.
 1+
 16.6/17.1
 15.8/16.3
 14.2/14.5
 invasive ductal
3
 2
 1a
 2
 70% pos.
 pos.
 1+
 17.2/17.7
 16.4/16.6
 14.3/14.0
 mixed (duct./lob)
6
 1c
 3a
 3
 >90% pos.
 pos.
 3+
 15.7/16.2
 17.2/18.1
 14.5/15.4
 invasive ductal
8
 2
 2a
 3
 >90% pos.
 pos.
 2+
 16.5/17.2
 15.8/16.3
 14.7/14.7
 invasive ductal
10
 1c
 N.A.
 2
 >90% pos.
 pos.
 2+
 14.5/16.6
 15.2/16.2
 13.5/14.4
 invasive ductal
13
 2
 3a
 3
 >90% pos.
 neg.
 1+
 16.6/17.0
 15.7/15.6
 14.6/14.5
 invasive ductal
14
 1c
 N.A.
 2
 >90% pos.
 neg.
 1+
 16.5/16.9
 16.2/16.4
 13.8/13.5
 invasive ductal
15
N.A.
 3
 neg.
 neg.
 0
 11.8/13.0
 14.9/15.5
 14.9/15.5
 invasive ductal
16
 2
 N.A.
 1
 65% pos.
 pos.
 0
 17.9/18.3
 16.4/16.6
 13.8/14.1
 invasive ductal/cribriform
17
 2
 0
 3
 >90% pos.
 pos.
 2+
 16.5/17.2
 16.3/16.9
 14.9/15.6
 invasive ductal
18
 2
 N.A.
 3
 neg.
 neg.
 0
 13.0/12.9
 15.1/15.9
 15.2/16.0
 invasive ductal
19
 2
 N.A.
 2
 >90% pos.
 pos.
 0
 17.2/17.6
 15.9/16.0
 13.8/14.2
 invasive ductal
20
 1c
 N.A.
 2
 neg.
 neg.
 0
 12.4/13.0
 15.7/15.9
 14.6/15.2
 invasive ductal
22
 2
 0
 2
 N.A.
 N.A.
 N.A.
 16.8/17.4
 15.6/16.1
 13.3/13.9
 invasive ductal

Oberli et al. BMC Medical Genomics 2008 1:9   doi:10.1186/1755-8794-1-9